NASDAQ · Healthcare · Biotechnology
Ascendis Pharma A/S
ASND
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. CEO Jan Moller Mikkelsen · Market cap $15.7B.
$252.07
-1.22 · -0.48%
52w hi $282.1552w lo $186.05
Off 52w high 11.8%
57
ROUTINE
Current InsiderScore
Corp · 90d
3
3 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $304.36
Section 01
Recent Form 4 filings
4 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 14 | Jean Jacques Bienaime | Buy | 900 | $246.91 | +$222K | 54 | |
| Aug 14 | Jean Jacques Bienaime | Buy | 1,100 | $245.85 | +$270K | 57 | |
| May 26 | Jean Jacques Bienaime | Buy | 200 | $236.24 | +$47K | 44 | |
| May 11 | Flemming Steen Jensen | EVP & Product Supply and Quality | Sell | 19,460 | $238.49 | −$4.64M | 37 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug